Dr. Adegunsoye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-2860
Summary
- Dr. Ayodeji Adegunsoye is a pulmonologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center, Glenbrook Hospital, NorthShore Skokie Hospital, Evanston Hospital, and Highland Park Hospital. He received his medical degree from University of Ibadan and has been in practice 13 years. He specializes in critical care medicine and pleural disease and is experienced in pneumonia, chronic obstructive pulmonary disease, interstitial lung disease, critical care medicine, and adult respiratory distress syndrome.
Education & Training
- University of ChicagoPh.D., Genetics, Genomics, and Systems Biology , 2019 - 2023
- University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2017
- University of ChicagoMS, Biostatistics and Epidemiology, 2016
- Mercy Catholic Medical CenterResidency, Internal Medicine, 2010 - 2013
- University of IbadanClass of 2004
Certifications & Licensure
- IL State Medical License 2013 - 2026
- PA State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis Start of enrollment: 2021 Jul 09
Publications & Presentations
PubMed
- 23 citationsCharacteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung DiseasesCathryn Lee, Ayodeji Adegunsoye, Jonathan H. Chung, Iazsmin Bauer Ventura, R. Jablonski
Chest. 2021-07-01 - 3 citationsAssociations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.John S Kim, Shwu-Fan Ma, Jennie Z Ma, Yong Huang, Catherine A Bonham
Chest. 2024-03-01 - 11 citationsTelomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts.Ayodeji Adegunsoye, Chad A Newton, Justin M Oldham, Brett Ley, Cathryn T Lee
Nature Communications. 2023-03-17
Journal Articles
- MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis.Adegunsoye A., Thorax., 12/31/2019
Press Mentions
- Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic?April 4th, 2023
- Black Patients Fare Worse with Deadly Lung Disease Pulmonary FibrosisMarch 15th, 2023
- Black Patients Are Diagnosed with, Hospitalized for and Die of Pulmonary Fibrosis at Younger Ages Than White PatientsMarch 10th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: